Compare TPG & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TPG | BLCO |
|---|---|---|
| Founded | 1992 | 1853 |
| Country | United States | Canada |
| Employees | 1900 | N/A |
| Industry | Investment Managers | Ophthalmic Goods |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 5.9B |
| IPO Year | N/A | 2022 |
| Metric | TPG | BLCO |
|---|---|---|
| Price | $42.61 | $16.16 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 11 |
| Target Price | ★ $61.20 | $18.45 |
| AVG Volume (30 Days) | ★ 2.6M | 432.9K |
| Earning Date | 05-01-2026 | 04-29-2026 |
| Dividend Yield | ★ 4.89% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $5,101,000,000.00 |
| Revenue This Year | N/A | $8.65 |
| Revenue Next Year | $19.79 | $5.59 |
| P/E Ratio | $106.82 | ★ N/A |
| Revenue Growth | N/A | ★ 6.47 |
| 52 Week Low | $36.95 | $10.99 |
| 52 Week High | $70.38 | $18.92 |
| Indicator | TPG | BLCO |
|---|---|---|
| Relative Strength Index (RSI) | 46.15 | 50.08 |
| Support Level | $41.43 | $14.39 |
| Resistance Level | $46.61 | $16.61 |
| Average True Range (ATR) | 1.82 | 0.49 |
| MACD | -0.13 | 0.03 |
| Stochastic Oscillator | 19.45 | 78.26 |
TPG Inc is an alternative asset management firm. It invests across five multi-product platforms, namely Capital, Growth, Impact, Real Estate, Market Solutions, and TPG Angelo Gordon. The company invests across a broadly diversified set of strategies, including private equity, impact, credit, real estate, market solutions, innovation, and inclusion.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.